ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1,3,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2,1,Conjunctival haemorrhage,Conjunctival and corneal bleeding and vascular disorders,Ocular haemorrhages and vascular disorders NEC,Eye,N
3,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
3,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
4,1,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
4,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
5,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
5,2,Joint effusion,Joint related signs and symptoms,Joint disorders,Musc,N
5,3,Knee deformity,Extremity deformities,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
5,4,Synovitis,Synovial disorders,Synovial and bursal disorders,Musc,N
6,1,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
7,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
8,1,Prothrombin time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
9,1,Haemolytic anaemia,Anaemias haemolytic NEC,Haemolyses and related conditions,Blood,N
10,1,Cyst,Mass conditions NEC,Tissue disorders NEC,Genrl,N
10,2,Rectal cancer,Colorectal neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
11,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
11,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
12,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
13,1,Brain oedema,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
13,2,Cerebellar ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
13,3,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
13,4,Dementia,Dementia (excl Alzheimer's type),Mental impairment disorders,Nerv,N
13,5,Encephalitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
13,6,Encephalitis viral,Viral infections NEC,Viral infectious disorders,Infec,N
13,7,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
13,8,HIV-associated neurocognitive disorder,Retroviral infections,Viral infectious disorders,Infec,N
13,9,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
13,10,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
13,11,Viral load increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
14,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
15,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
16,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
16,2,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
16,3,Headache,Headaches NEC,Headaches,Nerv,N
17,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
18,1,Myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
19,1,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
19,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
19,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
19,4,Thought blocking,Thinking disturbances,Disturbances in thinking and perception,Psych,N
20,1,Conjunctival hyperaemia,"Conjunctival infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
20,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
21,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
21,2,Amniotic cavity infection,Female reproductive tract infections,Infections - pathogen unspecified,Infec,N
21,3,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
21,4,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
22,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
22,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
22,3,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
23,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
23,2,Myoglobin blood increased,Musculoskeletal and soft tissue tests NEC,Musculoskeletal and soft tissue investigations (excl enzyme tests),Inv,N
24,1,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
24,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
24,3,HIV infection,Retroviral infections,Viral infectious disorders,Infec,N
24,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
24,5,Spinal stenosis,Spine and neck deformities,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
25,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
25,2,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
25,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
25,4,Myalgia,Muscle pains,Muscle disorders,Musc,N
25,5,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
26,1,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
26,2,Blood immunoglobulin E increased,Immunoglobulin analyses,Immunology and allergy investigations,Inv,N
26,3,Cachexia,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
26,4,Cholestasis,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
26,5,Chromaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
26,6,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
26,7,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
26,8,Hepatic encephalopathy,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
26,9,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
26,10,Hepatic necrosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
26,11,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
26,12,Hepatomegaly,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
26,13,Hyperlipidaemia,Hyperlipidaemias NEC,Lipid metabolism disorders,Metab,N
26,14,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
26,15,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
26,16,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
26,17,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
26,18,Myopathy,Myopathies,Muscle disorders,Musc,N
26,19,Ocular icterus,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
26,20,Ocular icterus,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
26,21,Pharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
26,22,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
26,23,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
26,24,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
26,25,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
26,26,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
26,27,Transplant dysfunction,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
26,28,Transplant rejection,Transplant rejections,Immune disorders NEC,Immun,N
27,1,Acute haemorrhagic conjunctivitis,Enteroviral infections NEC,Viral infectious disorders,Infec,N
27,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
27,3,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
27,4,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
27,5,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
27,6,Eye disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
27,7,Headache,Headaches NEC,Headaches,Nerv,N
27,8,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
27,9,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
27,10,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
27,11,Oral disorder,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
27,12,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
27,13,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
27,14,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
27,15,Tearfulness,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
27,16,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,Y
27,17,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
28,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
28,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
28,3,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
28,4,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
28,5,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
28,6,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
28,7,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
28,8,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
28,9,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
28,10,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
28,11,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
28,12,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
28,13,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
28,14,Headache,Headaches NEC,Headaches,Nerv,N
28,15,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
28,16,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
28,17,Incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
28,18,Musculoskeletal chest pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
28,19,Musculoskeletal pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
28,20,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
28,21,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
28,22,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
28,23,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
28,24,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
28,25,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
28,26,Sleep terror,Parasomnias,Sleep disorders and disturbances,Psych,N
28,27,Sneezing,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
28,28,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
28,29,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
28,30,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
29,1,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
30,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
30,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
30,3,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
31,1,Aortic valve sclerosis,Aortic valvular disorders,Cardiac valve disorders,Card,N
31,2,Apnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
31,3,Caesarean section,Obstetric therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
31,4,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
31,5,Cardiac murmur,Cardiac auscultatory investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
31,6,Complication of delivery,Maternal complications of delivery NEC,Maternal complications of labour and delivery,Preg,N
31,7,Congenital anomaly in offspring,Congenital disorders NEC,Congenital and hereditary disorders NEC,Cong,N
31,8,Congenital heart valve disorder,Cardiac valve disorders congenital,Cardiac and vascular disorders congenital,Cong,N
31,9,Congenital pulmonary valve disorder,Cardiac valve disorders congenital,Cardiac and vascular disorders congenital,Cong,N
31,10,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
31,11,Large for dates baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
31,12,Maternal drugs affecting foetus,Foetal and neonatal conditions associated with product exposure,"Exposures, chemical injuries and poisoning",Inj&P,N
31,13,Maternal exposure timing unspecified,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
31,14,Neonatal respiratory arrest,Neonatal hypoxic conditions,Neonatal respiratory disorders,Resp,N
31,15,Pulmonary valve sclerosis,Pulmonary valvular disorders,Cardiac valve disorders,Card,N
31,16,Sudden infant death syndrome,Death and sudden death,Fatal outcomes,Genrl,Y
31,17,Ventricular hypertrophy,Myocardial disorders NEC,Myocardial disorders,Card,N
32,1,Haemolytic uraemic syndrome,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
33,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
33,2,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
33,3,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
33,4,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
33,5,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
33,6,Decreased interest,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
33,7,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
33,8,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
33,9,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
33,10,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
33,11,Folliculitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
33,12,Intentional self-injury,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
33,13,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
33,14,Musculoskeletal discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
33,15,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
33,16,"Sleep disorder due to general medical condition, insomnia type",Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
33,17,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
34,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
34,2,Creatinine renal clearance,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
34,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
35,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
35,2,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
35,3,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
36,1,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
37,1,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
37,2,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
38,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
38,2,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
39,1,Dermatitis exfoliative generalised,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
39,2,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
40,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
40,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
40,3,Gestational diabetes,Pregnancy complicated by maternal disorders,Maternal complications of pregnancy,Preg,N
40,4,Lipodystrophy acquired,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
40,5,Premature labour,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
41,1,Caesarean section,Obstetric therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
41,2,Maternal exposure timing unspecified,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
42,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
42,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
42,3,Gestational diabetes,Pregnancy complicated by maternal disorders,Maternal complications of pregnancy,Preg,N
42,4,Lipodystrophy acquired,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
42,5,Premature labour,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
43,1,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
44,1,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
44,2,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
44,3,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
45,1,Anal atresia,Anorectal disorders congenital,Gastrointestinal tract disorders congenital,Cong,N
45,2,Anencephaly,Cerebral disorders congenital,Neurological disorders congenital,Cong,N
45,3,Bladder agenesis,Bladder disorders congenital,Renal and urinary tract disorders congenital,Cong,N
45,4,Bladder agenesis,Bladder disorders congenital,Renal and urinary tract disorders congenital,Cong,N
45,5,Blood iron decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
45,6,Blood iron decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
45,7,Caudal regression syndrome,Musculoskeletal and connective tissue disorders of spine congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
45,8,Cloacal exstrophy,Reproductive tract disorders congenital NEC,Reproductive tract and breast disorders congenital,Cong,N
45,9,Congenital anomaly,Congenital disorders NEC,Congenital and hereditary disorders NEC,Cong,N
45,10,Congenital ectopic bladder,Bladder disorders congenital,Renal and urinary tract disorders congenital,Cong,N
45,11,Congenital genital malformation,Reproductive tract disorders congenital NEC,Reproductive tract and breast disorders congenital,Cong,N
45,12,Congenital musculoskeletal disorder,Musculoskeletal disorders congenital NEC,Musculoskeletal and connective tissue disorders congenital,Cong,N
45,13,Congenital musculoskeletal disorder of spine,Musculoskeletal and connective tissue disorders of spine congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
45,14,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
45,15,Exomphalos,Gastrointestinal tract disorders congenital NEC,Gastrointestinal tract disorders congenital,Cong,N
45,16,Exomphalos,Gastrointestinal tract disorders congenital NEC,Gastrointestinal tract disorders congenital,Cong,N
45,17,Exomphalos,Gastrointestinal tract disorders congenital NEC,Gastrointestinal tract disorders congenital,Cong,N
45,18,Fibrosis,Fibrosis NEC,Tissue disorders NEC,Genrl,N
45,19,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
45,20,Gastrointestinal disorder congenital,Gastrointestinal tract disorders congenital NEC,Gastrointestinal tract disorders congenital,Cong,N
45,21,Gastrointestinal disorder congenital,Gastrointestinal tract disorders congenital NEC,Gastrointestinal tract disorders congenital,Cong,N
45,22,Gastrointestinal malformation,Gastrointestinal tract disorders congenital NEC,Gastrointestinal tract disorders congenital,Cong,N
45,23,Genitalia external ambiguous,Reproductive tract disorders congenital NEC,Reproductive tract and breast disorders congenital,Cong,N
45,24,Lipodystrophy acquired,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
45,25,Lipodystrophy acquired,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
45,26,Meconium stain,Amniotic fluid and cavity disorders of pregnancy NEC,"Placental, amniotic and cavity disorders (excl haemorrhages)",Preg,N
45,27,Meningomyelocele,Central nervous system disorders congenital NEC,Neurological disorders congenital,Cong,N
45,28,Meningomyelocele,Central nervous system disorders congenital NEC,Neurological disorders congenital,Cong,N
45,29,Musculoskeletal deformity,Extremity deformities,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
45,30,Musculoskeletal discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
45,31,Neural tube defect,Central nervous system disorders congenital NEC,Neurological disorders congenital,Cong,N
45,32,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
45,33,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
45,34,Sepsis neonatal,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
45,35,Spina bifida,Central nervous system disorders congenital NEC,Neurological disorders congenital,Cong,N
45,36,Tethered cord syndrome,Spinal cord and nerve root disorders NEC,Spinal cord and nerve root disorders,Nerv,N
45,37,Umbilical cord abnormality,Umbilical cord complications,Neonatal and perinatal conditions,Preg,N
45,38,Umbilical cord abnormality,Umbilical cord complications,Neonatal and perinatal conditions,Preg,N
46,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
46,2,Hyperlipidaemia,Hyperlipidaemias NEC,Lipid metabolism disorders,Metab,N
47,1,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
48,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
48,2,Hyperlipidaemia,Hyperlipidaemias NEC,Lipid metabolism disorders,Metab,N
48,3,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
48,4,Type 2 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
49,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
49,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
50,1,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
50,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
50,3,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
50,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
50,5,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
51,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
52,1,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
52,2,Eosinophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
52,3,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
52,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
53,1,Intestinal malrotation,Intestinal disorders congenital,Gastrointestinal tract disorders congenital,Cong,N
54,1,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
54,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
54,3,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
55,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
55,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
56,1,Arthritis bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
56,2,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
57,1,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
57,2,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
58,1,Renal colic,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
59,1,Central nervous system inflammation,Central nervous system inflammatory disorders NEC,Central nervous system infections and inflammations,Nerv,N
59,2,Cerebellar ataxia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
59,3,Dementia,Dementia (excl Alzheimer's type),Mental impairment disorders,Nerv,N
59,4,Encephalitis viral,Viral infections NEC,Viral infectious disorders,Infec,N
59,5,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
59,6,HIV-associated neurocognitive disorder,Retroviral infections,Viral infectious disorders,Infec,N
59,7,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
59,8,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
59,9,Viral load increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
60,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
60,2,Idiopathic pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
60,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
60,4,Pulmonary function test decreased,Respiratory and pulmonary function diagnostic procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
61,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
61,2,Low birth weight baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
61,3,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
62,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
62,2,Premature labour,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
63,1,Hepatic cirrhosis,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,N
64,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
64,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
64,3,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
64,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
64,5,Myalgia,Muscle pains,Muscle disorders,Musc,N
65,1,Metastatic neoplasm,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
65,2,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
66,1,Suicide attempt,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
67,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
68,1,Premature delivery,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
68,2,Premature rupture of membranes,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
69,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
69,2,Hydronephrosis,Renal obstructive disorders,Renal disorders (excl nephropathies),Renal,N
69,3,Retroperitoneal fibrosis,Peritoneal and retroperitoneal fibrosis and adhesions,Peritoneal and retroperitoneal conditions,Gastr,N
70,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
70,2,Low birth weight baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
71,1,Encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
72,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
73,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
74,1,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
74,2,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
75,1,Caesarean section,Obstetric therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
75,2,Live birth,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
75,3,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
75,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
75,5,Premature delivery,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
75,6,Premature rupture of membranes,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
75,7,Uterine leiomyoma,Uterine neoplasms benign,Reproductive neoplasms female benign,Neopl,N
76,1,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
76,2,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
77,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
77,2,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
77,3,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
78,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
79,1,Pneumonia pneumococcal,Streptococcal infections,Bacterial infectious disorders,Infec,N
80,1,Blood HIV RNA increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
80,2,CD4 lymphocytes decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
80,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
81,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
81,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
82,1,Complication of pregnancy,Maternal complications of pregnancy NEC,Maternal complications of pregnancy,Preg,N
82,2,Maternal exposure timing unspecified,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
82,3,Premature labour,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
83,1,Low birth weight baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
83,2,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
83,3,Small for dates baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
84,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
84,2,Enterococcal bacteraemia,Enterococcal infections,Bacterial infectious disorders,Infec,N
84,3,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
84,4,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
84,5,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
84,6,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
84,7,Traumatic intracranial haemorrhage,Cerebral injuries NEC,Injuries NEC,Inj&P,N
85,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
85,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
86,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
87,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
87,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
87,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
87,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
88,1,Upper gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
89,1,Bronchiolitis,Viral infections NEC,Viral infectious disorders,Infec,N
89,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
89,3,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
90,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
90,2,Polydactyly,Musculoskeletal and connective tissue disorders of limbs congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
91,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
91,2,Volvulus,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
92,1,Gastric haemorrhage,Gastric and oesophageal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
93,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
94,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
95,1,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
96,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
97,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
97,2,Renal dysplasia,Renal disorders congenital,Renal and urinary tract disorders congenital,Cong,N
98,1,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
99,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
99,2,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
99,3,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
100,1,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
101,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
101,2,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
102,1,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
102,2,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
103,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
103,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
103,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
103,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
103,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
103,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
104,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
104,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
104,3,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
104,4,Coronary artery disease,Coronary artery disorders NEC,Coronary artery disorders,Card,N
104,5,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
104,6,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
104,7,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
104,8,HIV associated nephropathy,Retroviral infections,Viral infectious disorders,Infec,N
104,9,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
104,10,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
104,11,Induration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
104,12,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
104,13,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
104,14,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
104,15,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
104,16,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
104,17,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
104,18,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
104,19,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
104,20,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,Y
104,21,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
105,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
105,2,Lipids increased,Lipoprotein and lipid tests NEC,Lipid analyses,Inv,N
105,3,Migraine,Migraine headaches,Headaches,Nerv,N
105,4,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
105,5,Secondary hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
106,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
106,2,Mechanical ventilation,Respiratory tract therapeutic procedures NEC,Respiratory tract therapeutic procedures,Surg,N
107,1,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
107,2,Apathy,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
107,3,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
107,4,Dissociation,Dissociative states,Dissociative disorders,Psych,N
108,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
109,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
109,2,Urine abnormality,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
110,1,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
111,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
111,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
111,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
111,4,Lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,N
111,5,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
112,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
113,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
113,2,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
113,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
113,4,Haemophilic arthropathy,Arthropathies NEC,Joint disorders,Musc,N
113,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
114,1,Gastrointestinal tube insertion,Gastrointestinal therapeutic procedures NEC,Gastrointestinal therapeutic procedures,Surg,N
114,2,Infarction,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
114,3,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
114,4,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
115,1,Burkitt's lymphoma,Burkitt's lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
115,2,Mechanical ventilation,Respiratory tract therapeutic procedures NEC,Respiratory tract therapeutic procedures,Surg,N
116,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
116,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
117,1,Bladder disorder,Bladder disorders NEC,Bladder and bladder neck disorders (excl calculi),Renal,N
117,2,Congenital cystic kidney disease,Renal disorders congenital,Renal and urinary tract disorders congenital,Cong,N
117,3,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
117,4,Vesicoureteric reflux,Bladder reflux conditions,Bladder and bladder neck disorders (excl calculi),Renal,N
118,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
119,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
119,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
120,1,Encephalitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
120,2,Lymphocytosis,Leukocytoses NEC,White blood cell disorders,Blood,N
121,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
122,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,Y
122,2,Acidosis,Mixed acid-base disorders,Acid-base disorders,Metab,N
122,3,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
122,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
122,5,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
122,6,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
122,7,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
122,8,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
123,1,Congenital bladder anomaly,Bladder disorders congenital,Renal and urinary tract disorders congenital,Cong,N
123,2,Congenital cystic kidney disease,Renal disorders congenital,Renal and urinary tract disorders congenital,Cong,N
123,3,Congenital vesicoureteric reflux,Bladder disorders congenital,Renal and urinary tract disorders congenital,Cong,N
123,4,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
124,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
124,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
125,1,Immune reconstitution inflammatory syndrome associated Kaposi's sarcoma,Kaposi's sarcomas,Soft tissue neoplasms malignant and unspecified,Neopl,Y
126,1,Alanine aminotransferase abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
126,2,Aspartate aminotransferase abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
126,3,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
126,4,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
126,5,Lipodystrophy acquired,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
126,6,Premature labour,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
127,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
127,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
128,1,Body temperature fluctuation,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
128,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
128,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
128,4,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
128,5,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
128,6,Flank pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
128,7,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
128,8,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
128,9,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
128,10,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
128,11,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
128,12,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
129,1,Lymphocyte count abnormal,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
129,2,Lymphocytosis,Leukocytoses NEC,White blood cell disorders,Blood,N
129,3,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
130,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
130,2,Gastrointestinal tube insertion,Gastrointestinal therapeutic procedures NEC,Gastrointestinal therapeutic procedures,Surg,N
131,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
131,2,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
131,3,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
131,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
131,5,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
132,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
132,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
132,3,Cardiac failure,Heart failures NEC,Heart failures,Card,N
132,4,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
132,5,Hydrocephalus,Hydrocephalic conditions,Increased intracranial pressure and hydrocephalus,Nerv,N
132,6,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
132,7,Hypotonia,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
132,8,Intraventricular haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
132,9,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
132,10,Necrosis,Necrosis NEC,Tissue disorders NEC,Genrl,N
132,11,Renal tubular necrosis,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
132,12,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
132,13,Thymus hypoplasia,Immune system abnormalities congenital,Immune system disorders congenital,Cong,N
133,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
134,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
134,2,Gastrointestinal tube insertion,Gastrointestinal therapeutic procedures NEC,Gastrointestinal therapeutic procedures,Surg,N
135,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
135,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
135,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
135,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
136,1,Encephalitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
136,2,Gastrointestinal tube insertion,Gastrointestinal therapeutic procedures NEC,Gastrointestinal therapeutic procedures,Surg,N
137,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
138,1,Haemodialysis,Renal therapeutic procedures,Renal and urinary tract therapeutic procedures,Surg,N
138,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
139,1,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
140,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
140,2,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
140,3,Type I hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
140,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
141,1,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,Y
142,1,Affect lability,Affect alterations NEC,Mood disorders and disturbances NEC,Psych,N
142,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
142,3,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
142,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
143,1,Aortic aneurysm,Aortic aneurysms and dissections,Aneurysms and artery dissections,Vasc,N
143,2,Aortic dilatation,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
144,1,Blood potassium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
144,2,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
144,3,Product label issue,Product label issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
144,4,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
144,5,Ventricular fibrillation,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
144,6,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
145,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
145,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
146,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
146,2,Gastrointestinal tube insertion,Gastrointestinal therapeutic procedures NEC,Gastrointestinal therapeutic procedures,Surg,N
146,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
147,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
148,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
149,1,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
150,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
151,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
151,2,Low birth weight baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
151,3,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
152,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
153,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
154,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
154,2,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
154,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
154,4,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
154,5,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
155,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
155,2,Gastrointestinal tube insertion,Gastrointestinal therapeutic procedures NEC,Gastrointestinal therapeutic procedures,Surg,N
156,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
156,2,Gastrointestinal tube insertion,Gastrointestinal therapeutic procedures NEC,Gastrointestinal therapeutic procedures,Surg,N
156,3,Intensive care,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
157,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
158,1,Gastrostomy,Gastric therapeutic procedures,Gastrointestinal therapeutic procedures,Surg,N
159,1,Dystonia,Dystonias,Movement disorders (incl parkinsonism),Nerv,N
160,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
160,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
160,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
160,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
160,5,Transaminases increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
161,1,Transient global amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
162,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
163,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
164,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
164,2,Stillbirth,Stillbirth and foetal death,Abortions and stillbirth,Preg,N
165,1,Abdominal neoplasm,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
166,1,Asphyxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,Y
166,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
166,3,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
167,1,Gastrointestinal tube insertion,Gastrointestinal therapeutic procedures NEC,Gastrointestinal therapeutic procedures,Surg,N
167,2,Intensive care,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
167,3,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
168,1,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
168,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
169,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
170,1,Congenital hand malformation,Musculoskeletal and connective tissue disorders of limbs congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
170,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
170,3,Premature baby death,Death and sudden death,Fatal outcomes,Genrl,Y
171,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
172,1,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
172,2,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
173,1,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
173,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
174,1,Endocrine ophthalmopathy,"Structural change, deposit and degeneration of eye NEC","Ocular structural change, deposit and degeneration NEC",Eye,N
175,1,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
175,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
176,1,Aplasia pure red cell,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
176,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
176,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
177,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
177,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
178,1,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
178,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
179,1,Blood potassium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
179,2,Haemodialysis,Renal therapeutic procedures,Renal and urinary tract therapeutic procedures,Surg,N
180,1,Foetal distress syndrome,Foetal complications NEC,Foetal complications,Preg,N
180,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
181,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
182,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
183,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
184,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
184,2,Stillbirth,Stillbirth and foetal death,Abortions and stillbirth,Preg,N
185,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
185,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
186,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
186,2,Emotional disorder,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
186,3,Formication,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
186,4,Social avoidant behaviour,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
187,1,Gastrointestinal tube insertion,Gastrointestinal therapeutic procedures NEC,Gastrointestinal therapeutic procedures,Surg,N
187,2,Mechanical ventilation,Respiratory tract therapeutic procedures NEC,Respiratory tract therapeutic procedures,Surg,N
187,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
188,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
189,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
190,1,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
191,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
192,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
192,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
193,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
194,1,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
195,1,Caesarean section,Obstetric therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
195,2,Live birth,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
195,3,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
195,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
195,5,Premature delivery,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
195,6,Premature rupture of membranes,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
195,7,Uterine leiomyoma,Uterine neoplasms benign,Reproductive neoplasms female benign,Neopl,N
196,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
197,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
197,2,Ventricular fibrillation,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
198,1,Headache,Headaches NEC,Headaches,Nerv,N
199,1,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
199,2,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
200,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
200,2,Epstein-Barr viraemia,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
200,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
200,4,Transaminases increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
201,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
202,1,Hepatitis acute,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
203,1,Petechiae,Purpura and related conditions,Skin vascular abnormalities,Skin,N
203,2,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
204,1,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
204,2,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
205,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
205,2,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
205,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
206,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
206,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
206,3,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
207,1,Foetal distress syndrome,Foetal complications NEC,Foetal complications,Preg,N
207,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
207,3,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
208,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
208,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
208,3,Premature labour,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
209,1,Foetal distress syndrome,Foetal complications NEC,Foetal complications,Preg,N
209,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
209,3,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
210,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
210,2,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
211,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
211,2,Premature labour,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
212,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
213,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
213,2,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
213,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
213,4,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
214,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
215,1,Gastrointestinal tube insertion,Gastrointestinal therapeutic procedures NEC,Gastrointestinal therapeutic procedures,Surg,N
216,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
216,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
217,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
218,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
218,2,Hypothermia,Body temperature altered,Body temperature conditions,Genrl,N
219,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
219,2,Hypothermia,Body temperature altered,Body temperature conditions,Genrl,N
220,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
220,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
221,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
222,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
223,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
224,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
225,1,Hypersomnia,Narcolepsy and hypersomnia,Sleep disturbances (incl subtypes),Nerv,N
225,2,Loss of personal independence in daily activities,Disability issues,Lifestyle issues,SocCi,N
225,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
225,4,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
225,5,Viral load increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
225,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
226,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
227,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
228,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
228,2,Intentional self-injury,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
228,3,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
229,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
229,2,Head injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
230,1,Folliculitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
231,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
232,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
232,2,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
233,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
233,2,Circumstance or information capable of leading to medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
233,3,Gastrointestinal tube insertion,Gastrointestinal therapeutic procedures NEC,Gastrointestinal therapeutic procedures,Surg,N
233,4,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
234,1,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
235,1,Tooth discolouration,Dental surface disorders,Dental and gingival conditions,Gastr,N
236,1,Accident,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
237,1,Accident,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
238,1,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
239,1,Accident,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
240,1,Lung neoplasm malignant,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
241,1,Lung neoplasm malignant,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
242,1,Lung neoplasm malignant,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
243,1,Lung neoplasm malignant,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
244,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
244,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
244,3,Loss of personal independence in daily activities,Disability issues,Lifestyle issues,SocCi,N
244,4,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
245,1,Epidermodysplasia verruciformis,Papilloma viral infections,Viral infectious disorders,Infec,N
245,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
246,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
246,2,Loss of personal independence in daily activities,Disability issues,Lifestyle issues,SocCi,N
246,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
246,4,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
247,1,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
248,1,Ileostomy,Small intestine therapeutic procedures,Gastrointestinal therapeutic procedures,Surg,N
248,2,Small intestinal resection,Small intestine therapeutic procedures,Gastrointestinal therapeutic procedures,Surg,N
249,1,Embolic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
249,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
250,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
250,2,Low birth weight baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
250,3,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
250,4,Small for dates baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
251,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
251,2,Low birth weight baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
252,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
253,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
254,1,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
255,1,Dementia,Dementia (excl Alzheimer's type),Mental impairment disorders,Nerv,N
256,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
256,2,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
256,3,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
256,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
257,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
258,1,Chemotherapy,Chemotherapies,Therapeutic procedures and supportive care NEC,Surg,N
258,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
258,3,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
259,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
260,1,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
260,2,Injury,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
261,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
262,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
262,2,Radiotherapy,Radiotherapies site unspecified,Therapeutic procedures and supportive care NEC,Surg,N
263,1,Hereditary ataxia,Cerebellar disorders congenital,Neurological disorders congenital,Cong,N
264,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
265,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
265,2,Dermatitis exfoliative generalised,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
265,3,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
265,4,Generalised anxiety disorder,Anxiety disorders NEC,Anxiety disorders and symptoms,Psych,N
265,5,Hyperbilirubinaemia,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
265,6,Live birth,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
265,7,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
265,8,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
265,9,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
265,10,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
265,11,Social avoidant behaviour,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
266,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
267,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
268,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
268,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
268,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
268,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
268,5,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
268,6,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
268,7,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
269,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
270,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
270,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
270,3,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
271,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
272,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
272,2,Headache,Headaches NEC,Headaches,Nerv,N
272,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
272,4,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
273,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
274,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
274,2,Generalised anxiety disorder,Anxiety disorders NEC,Anxiety disorders and symptoms,Psych,N
274,3,Hyperbilirubinaemia,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
274,4,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
274,5,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
274,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
274,7,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
275,1,Gastrointestinal tube insertion,Gastrointestinal therapeutic procedures NEC,Gastrointestinal therapeutic procedures,Surg,N
276,1,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
277,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
277,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
277,3,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
278,1,Colitis microscopic,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
279,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
279,2,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
279,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
280,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
281,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
282,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
282,2,Activated partial thromboplastin time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
282,3,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
282,4,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
282,5,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
282,6,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
282,7,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
282,8,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
282,9,Bilirubin conjugated increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
282,10,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
282,11,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
282,12,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
282,13,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
282,14,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
282,15,Eosinophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
282,16,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
282,17,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
282,18,Headache,Headaches NEC,Headaches,Nerv,N
282,19,Hepatic steatosis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
282,20,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
282,21,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
282,22,Infusion site vesicles,Infusion site reactions,Administration site reactions,Genrl,N
282,23,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
282,24,Liver tenderness,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
282,25,Myalgia,Muscle pains,Muscle disorders,Musc,N
282,26,Ocular icterus,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
282,27,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
282,28,Protein total increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
282,29,Prothrombin time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
282,30,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
282,31,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
282,32,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
282,33,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
282,34,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
283,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
283,2,Circumstance or information capable of leading to medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
283,3,Gastrointestinal tube insertion,Gastrointestinal therapeutic procedures NEC,Gastrointestinal therapeutic procedures,Surg,N
284,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
285,1,CD4 lymphocytes decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
285,2,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
285,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
285,4,Radiation skin injury,Radiation injuries,Injuries by physical agents,Inj&P,N
285,5,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
286,1,Glycosylated haemoglobin increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
286,2,Thirst,Feelings and sensations NEC,General system disorders NEC,Genrl,N
287,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
287,2,Renal transplant,Renal therapeutic procedures,Renal and urinary tract therapeutic procedures,Surg,N
287,3,Tubulointerstitial nephritis,Nephritis NEC,Nephropathies,Renal,N
288,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
288,2,Gastrointestinal tube insertion,Gastrointestinal therapeutic procedures NEC,Gastrointestinal therapeutic procedures,Surg,N
289,1,Headache,Headaches NEC,Headaches,Nerv,N
289,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
290,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
290,2,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
290,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
290,4,Dissociation,Dissociative states,Dissociative disorders,Psych,N
290,5,Flat affect,Affect alterations NEC,Mood disorders and disturbances NEC,Psych,N
290,6,Headache,Headaches NEC,Headaches,Nerv,N
290,7,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
290,8,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
290,9,Hyposmia,Olfactory nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
290,10,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
290,11,Oligodipsia,Fluid intake decreased,Electrolyte and fluid balance conditions,Metab,N
290,12,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
290,13,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
290,14,Therapeutic response unexpected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
290,15,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
291,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
292,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
293,1,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
293,2,Exfoliative rash,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
293,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
294,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
294,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
295,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
295,2,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
295,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
295,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
295,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
295,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
296,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
296,2,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
296,3,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
296,4,Exfoliative rash,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
296,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
296,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
297,1,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
297,2,Viral mutation identified,Virus identification and serology,Microbiology and serology investigations,Inv,N
298,1,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
298,2,Viral mutation identified,Virus identification and serology,Microbiology and serology investigations,Inv,N
299,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
300,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
300,2,Headache,Headaches NEC,Headaches,Nerv,N
301,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
302,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
302,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
303,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
303,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
303,3,Eosinophilia,Eosinophilic disorders,White blood cell disorders,Blood,N
303,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
303,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
303,6,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
303,7,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
303,8,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
304,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
304,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
304,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
304,4,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
304,5,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
304,6,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
304,7,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
304,8,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
305,1,Depression suicidal,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
305,2,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
306,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
306,2,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
307,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
307,2,Sepsis syndrome,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
308,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
309,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
309,2,Circumstance or information capable of leading to medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
309,3,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
310,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
310,2,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
310,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
310,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
310,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
311,1,Ophthalmic herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
312,1,Myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
313,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
314,1,Myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
315,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
315,2,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
315,3,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
315,4,Product formulation issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
316,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
316,2,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
316,3,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
316,4,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
316,5,Scab,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
317,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
317,2,Low birth weight baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
318,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
318,2,Low birth weight baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
318,3,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
319,1,Tendonitis,Tendon disorders,"Tendon, ligament and cartilage disorders",Musc,N
320,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
320,2,Premature delivery,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
321,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
321,2,Low birth weight baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
321,3,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
321,4,Small for dates baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
322,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
322,2,Premature delivery,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
322,3,Premature labour,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
323,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
323,2,Premature delivery,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
324,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
324,2,Low birth weight baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
324,3,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
324,4,Small for dates baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
325,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
325,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
326,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
327,1,Emotional poverty,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
327,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
327,3,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
327,4,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
328,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,Y
328,2,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
328,3,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
328,4,Caesarean section,Obstetric therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
328,5,Cleft lip and palate,Palate disorders congenital,Gastrointestinal tract disorders congenital,Cong,N
328,6,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
328,7,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
328,8,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
328,9,Hepatic cytolysis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
328,10,Hydrops foetalis,Foetal complications NEC,Foetal complications,Preg,N
328,11,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
328,12,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
328,13,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
328,14,Trisomy 18,Autosomal chromosomal abnormalities,"Chromosomal abnormalities, gene alterations and gene variants",Cong,N
328,15,Ultrasound antenatal screen,Foetal and neonatal imaging procedures,Foetal and neonatal investigations,Inv,N
329,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
329,2,Rash morbilliform,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
330,1,Myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
331,1,Faeces soft,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
331,2,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
332,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
333,1,Headache,Headaches NEC,Headaches,Nerv,N
334,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
334,2,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
334,3,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
335,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
335,2,Pericarditis,Noninfectious pericarditis,Pericardial disorders,Card,N
336,1,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
337,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
337,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
337,3,Headache,Headaches NEC,Headaches,Nerv,N
337,4,Myalgia,Muscle pains,Muscle disorders,Musc,N
338,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
338,2,Seronegative arthritis,Arthropathies NEC,Joint disorders,Musc,N
339,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
340,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
340,2,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
340,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
340,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
340,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
341,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
342,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
342,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
342,3,Headache,Headaches NEC,Headaches,Nerv,N
343,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
343,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
343,3,Headache,Headaches NEC,Headaches,Nerv,N
344,1,Deafness,Hearing losses,Hearing disorders,Ear,N
345,1,Hip fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
346,1,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
347,1,Perineal abscess,Muscle and soft tissue infections,Infections - pathogen unspecified,Infec,N
348,1,Perineal abscess,Muscle and soft tissue infections,Infections - pathogen unspecified,Infec,N
349,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
349,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
350,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
351,1,Brain injury,Structural brain disorders NEC,Structural brain disorders,Nerv,Y
351,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
351,3,Foetal growth abnormality,Foetal growth complications,Foetal complications,Preg,N
351,4,Foetal growth restriction,Foetal growth complications,Foetal complications,Preg,N
351,5,Gastroschisis,Gastrointestinal tract disorders congenital NEC,Gastrointestinal tract disorders congenital,Cong,N
352,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
352,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
352,3,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
353,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
354,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
354,2,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
355,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
355,2,Drug level decreased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
356,1,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
357,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
357,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
357,3,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
358,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
358,2,Premature delivery,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
359,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
359,2,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
359,3,Small for dates baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
360,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
360,2,Premature delivery,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
360,3,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
361,1,Gingivitis ulcerative,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
361,2,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
362,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
362,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
362,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
362,4,Myalgia,Muscle pains,Muscle disorders,Musc,N
363,1,Virologic failure,Infections NEC,Infections - pathogen unspecified,Infec,N
364,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
365,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
365,2,Reaction to excipient,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
365,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
366,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
367,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
367,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
367,3,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
368,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
368,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
369,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
369,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
369,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
370,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
370,2,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
371,1,Alopecia areata,Alopecias,Skin appendage conditions,Skin,N
371,2,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
372,1,Alopecia areata,Alopecias,Skin appendage conditions,Skin,N
372,2,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
373,1,Alopecia areata,Alopecias,Skin appendage conditions,Skin,N
373,2,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
374,1,Heart transplant,Cardiac therapeutic procedures NEC,Cardiac therapeutic procedures,Surg,N
375,1,Heart transplant,Cardiac therapeutic procedures NEC,Cardiac therapeutic procedures,Surg,N
376,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
376,2,Alopecia areata,Alopecias,Skin appendage conditions,Skin,N
376,3,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
377,1,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
378,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
378,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
379,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
380,1,Brain injury,Structural brain disorders NEC,Structural brain disorders,Nerv,N
380,2,Gastrointestinal tube insertion,Gastrointestinal therapeutic procedures NEC,Gastrointestinal therapeutic procedures,Surg,N
380,3,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
381,1,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
381,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
382,1,Lung neoplasm malignant,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
383,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
383,2,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
383,3,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
383,4,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
383,5,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
384,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
384,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
384,3,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
385,1,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
386,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
387,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
388,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
388,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
389,1,Haemolytic anaemia,Anaemias haemolytic NEC,Haemolyses and related conditions,Blood,N
390,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
391,1,Gastric infection,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
392,1,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
392,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
393,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
393,2,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
393,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
394,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
395,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
396,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
396,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
396,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
396,4,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
396,5,Feeling of body temperature change,Feelings and sensations NEC,General system disorders NEC,Genrl,N
396,6,Headache,Headaches NEC,Headaches,Nerv,N
396,7,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
396,8,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
396,9,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
396,10,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
397,1,Coronavirus infection,Coronavirus infections,Viral infectious disorders,Infec,N
397,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
398,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
399,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
400,1,Coronavirus infection,Coronavirus infections,Viral infectious disorders,Infec,N
401,1,Coronavirus infection,Coronavirus infections,Viral infectious disorders,Infec,N
402,1,Coronavirus infection,Coronavirus infections,Viral infectious disorders,Infec,N
403,1,Suspected COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
404,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
405,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
405,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
405,3,Delirium,Deliria,Deliria (incl confusion),Psych,N
405,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
405,5,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
405,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
405,7,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
405,8,Suspected COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
406,1,Chronic obstructive pulmonary disease,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
406,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
406,3,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
407,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
407,2,Patient isolation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
407,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
408,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
408,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
408,3,Delirium,Deliria,Deliria (incl confusion),Psych,N
408,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
408,5,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
408,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
408,7,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
408,8,Suspected COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
409,1,Chronic obstructive pulmonary disease,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
409,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
409,3,Product administered to patient of inappropriate age,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
410,1,Brain stem stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
410,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
410,3,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
411,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
412,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
413,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
413,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
413,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
413,4,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
413,5,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
414,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
414,2,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
415,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
416,1,Body temperature abnormal,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
416,2,Coronavirus infection,Coronavirus infections,Viral infectious disorders,Infec,N
416,3,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
416,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
416,5,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
416,6,SARS-CoV-2 antibody test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
417,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
418,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
418,2,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
418,3,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
418,4,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
418,5,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
419,1,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
419,2,Hepatitis fulminant,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
419,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
419,4,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
420,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
420,2,Enteral nutrition,Dietary and nutritional therapies,Therapeutic procedures and supportive care NEC,Surg,N
421,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
421,2,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
422,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
423,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
423,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
423,3,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
423,4,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
423,5,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
424,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
425,1,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
425,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
425,3,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
425,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
425,5,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
425,6,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
425,7,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
425,8,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
426,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
427,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
428,1,Oesophageal ulcer,Oesophageal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
429,1,Tonsillitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
430,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
431,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
432,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
433,1,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
434,1,Retinal toxicity,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
435,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
435,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
435,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
436,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
436,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
437,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
438,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
438,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
439,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
440,1,Alveolar osteitis,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
440,2,Tooth extraction,Dental and gingival therapeutic procedures,Head and neck therapeutic procedures,Surg,N
441,1,Pregnancy,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
442,1,Lymphoma,Lymphomas unspecified NEC,Lymphomas NEC,Neopl,N
443,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
443,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
444,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
445,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
446,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
447,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
447,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
448,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
449,1,Myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
450,1,Coronavirus infection,Coronavirus infections,Viral infectious disorders,Infec,N
450,2,Feeding disorder,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
450,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
451,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
452,1,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
453,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
454,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
454,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
454,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
454,4,Product prescribing issue,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
455,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
455,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
455,3,Upper limb fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
456,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
456,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
457,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
458,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
458,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
458,3,Delirium,Deliria,Deliria (incl confusion),Psych,N
458,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
458,5,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
458,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
458,7,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
458,8,Suspected COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
459,1,Intercepted medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
459,2,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
460,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
461,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
462,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
462,2,Inflammation,Inflammations,General system disorders NEC,Genrl,N
462,3,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
462,4,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
462,5,Myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
463,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
463,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
463,3,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
464,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
465,1,Intercepted medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
465,2,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
466,1,Product prescribing issue,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
467,1,Myositis,Muscle infections and inflammations,Muscle disorders,Musc,N
468,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
468,2,Infective myositis,Muscle and soft tissue infections,Infections - pathogen unspecified,Infec,N
469,1,Helicobacter infection,Helicobacter infections,Bacterial infectious disorders,Infec,N
470,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
471,1,Helicobacter infection,Helicobacter infections,Bacterial infectious disorders,Infec,N
472,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
472,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
473,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
474,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
474,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
475,1,Helicobacter infection,Helicobacter infections,Bacterial infectious disorders,Infec,N
476,1,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
477,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
478,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
478,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
478,3,Delirium,Deliria,Deliria (incl confusion),Psych,N
478,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
478,5,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
478,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
478,7,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
478,8,Suspected COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
479,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
479,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
479,3,Delirium,Deliria,Deliria (incl confusion),Psych,N
479,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
479,5,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
479,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
479,7,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
479,8,Suspected COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
480,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
481,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
482,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
483,1,Laryngectomy,Laryngeal therapeutic procedures,Head and neck therapeutic procedures,Surg,N
484,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
485,1,Living in residential institution,Housing circumstances,Economic and housing issues,SocCi,N
486,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
487,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
488,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
488,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
488,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
488,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
488,5,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
488,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
489,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
489,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
489,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
489,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
489,5,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
489,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
490,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
491,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
491,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
491,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
491,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
492,1,Circumstance or information capable of leading to medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
492,2,Gastrostomy,Gastric therapeutic procedures,Gastrointestinal therapeutic procedures,Surg,N
492,3,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
493,1,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
494,1,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
495,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
495,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
495,3,Coma,Coma states,Neurological disorders NEC,Nerv,N
495,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
496,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
497,1,Morning sickness,Maternal complications of pregnancy NEC,Maternal complications of pregnancy,Preg,N
498,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
499,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
499,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
499,3,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
499,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
499,5,Pruritus genital,Reproductive tract signs and symptoms NEC,Reproductive tract disorders NEC,Repro,N
499,6,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
500,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
500,2,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
500,3,Self-injurious ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
501,1,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
501,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
501,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
501,4,Product supply issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
502,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
503,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
504,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
504,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
505,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
506,1,Brain oedema,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
506,2,Central nervous system lesion,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
506,3,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
506,4,Headache,Headaches NEC,Headaches,Nerv,N
506,5,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
506,6,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
506,7,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
506,8,Inflammatory marker increased,Chemistry analyses NEC,Protein and chemistry analyses NEC,Inv,N
506,9,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
506,10,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
506,11,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
507,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
507,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
508,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
508,2,Pregnancy,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
509,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
509,2,Palliative care,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
510,1,Osteopenia,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
511,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,Y
511,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
512,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
513,1,Brain oedema,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
513,2,Central nervous system lesion,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
513,3,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
513,4,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
513,5,Headache,Headaches NEC,Headaches,Nerv,N
513,6,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
513,7,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
513,8,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
513,9,Inflammatory marker increased,Chemistry analyses NEC,Protein and chemistry analyses NEC,Inv,N
513,10,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
513,11,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
513,12,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
514,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
515,1,Gastric bypass,Gastric therapeutic procedures,Gastrointestinal therapeutic procedures,Surg,N
516,1,CD4 lymphocytes increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
517,1,Brain injury,Structural brain disorders NEC,Structural brain disorders,Nerv,N
517,2,Congenital intestinal malformation,Intestinal disorders congenital,Gastrointestinal tract disorders congenital,Cong,N
517,3,Foetal death,Stillbirth and foetal death,Abortions and stillbirth,Preg,Y
517,4,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
517,5,Foetal growth abnormality,Foetal growth complications,Foetal complications,Preg,N
517,6,Foetal growth restriction,Foetal growth complications,Foetal complications,Preg,N
517,7,Gastroschisis,Gastrointestinal tract disorders congenital NEC,Gastrointestinal tract disorders congenital,Cong,N
517,8,Hydrocephalus,Hydrocephalic conditions,Increased intracranial pressure and hydrocephalus,Nerv,N
517,9,Spina bifida,Central nervous system disorders congenital NEC,Neurological disorders congenital,Cong,N
518,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
518,2,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
518,3,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
518,4,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
518,5,Hepatic cytolysis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,Y
518,6,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
518,7,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
519,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
520,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
520,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
521,1,Dialysis,Renal therapeutic procedures,Renal and urinary tract therapeutic procedures,Surg,N
522,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
522,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
523,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
524,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
524,2,Pregnancy,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
525,1,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
525,2,Labelled drug-drug interaction issue,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
525,3,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
525,4,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
526,1,Brain stem stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
526,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
526,3,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
527,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
528,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
529,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
529,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
530,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
530,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
530,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
530,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
531,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
532,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
532,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
533,1,CD4 lymphocytes abnormal,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
534,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
535,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
536,1,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
537,1,Bone disorder,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
538,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
538,2,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
539,1,Bone disorder,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
540,1,Foetal exposure during delivery,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
540,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
540,3,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
540,4,Renal aplasia,Renal disorders congenital,Renal and urinary tract disorders congenital,Cong,N
540,5,Renal dysplasia,Renal disorders congenital,Renal and urinary tract disorders congenital,Cong,N
540,6,Single functional kidney,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
541,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
541,2,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
541,3,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
542,1,Retinal detachment,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
543,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
544,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
544,2,Low birth weight baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
545,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
546,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
547,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
548,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
549,1,Herpes virus infection,Herpes viral infections,Viral infectious disorders,Infec,N
550,1,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
551,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
552,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
552,2,Headache,Headaches NEC,Headaches,Nerv,N
553,1,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
554,1,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
555,1,Methaemoglobinaemia,Haematological disorders,Haematological disorders NEC,Blood,N
556,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
557,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
557,2,Viral load,Virus identification and serology,Microbiology and serology investigations,Inv,N
558,1,Hypersomnia,Narcolepsy and hypersomnia,Sleep disturbances (incl subtypes),Nerv,N
559,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
560,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
560,2,Low birth weight baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
561,1,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
562,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
563,1,"Sleep disorder due to general medical condition, hypersomnia type",Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
564,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
565,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
566,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
567,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
567,2,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
568,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
569,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
569,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
569,3,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
569,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
569,5,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
569,6,Mesenteric panniculitis,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
569,7,Necrotic lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
569,8,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
569,9,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
569,10,Viral mutation identified,Virus identification and serology,Microbiology and serology investigations,Inv,N
569,11,Virologic failure,Infections NEC,Infections - pathogen unspecified,Infec,N
570,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
571,1,Autoimmune hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
572,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
572,2,Viral load increased,Virus identification and serology,Microbiology and serology investigations,Inv,N
573,1,Pregnancy,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
573,2,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
574,1,Virologic failure,Infections NEC,Infections - pathogen unspecified,Infec,N
575,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
576,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
576,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
577,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
577,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
578,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
579,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
580,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
580,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
580,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
580,4,Viraemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
581,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
582,1,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
582,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
582,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
583,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
584,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
585,1,Anaemia macrocytic,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
585,2,Vitamin B12 deficiency,Water soluble vitamin deficiencies,Vitamin related disorders,Metab,N
586,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
587,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
588,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
589,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
590,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
591,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
591,2,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
591,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
591,4,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
591,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
592,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
593,1,Incorrect product formulation administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
593,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
593,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
593,4,Product prescribing issue,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
594,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
